Salofalk is indicated in (IBD) Inflammatory Bowel Diseases:
(1) Crohn's Disease.
(2) Ulcerative Colitis.
Where the normal mucosal homeostasis is altered with reduced ability of the GIT to distinguish foreign from self-antigens, or to down-regulate the mucosal immune response. This makes the self-limited Immune Elimination process proceeds to the Amplification Phase then to the Damage Phase.